Document Detail


Glutamate in opioid dependence.
MedLine Citation:
PMID:  9365966     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The present review will concentrate on a discussion of recent investigations which implicate a critical linkage of three facets of the central nervous system mediation of opioid dependence, as evidenced by expression of acutely-precipitated withdrawal events. These are the kappa-opioid receptor subtype, the glutamatergic neuronal system and a specific brain locus, the locus coeruleus. The impetus for this line of investigation derives from a recognition that opioid analgesics, such as butorphanol (Stadol), exhibit a markedly different profile of activity at opioid receptors than does morphine yet have abuse liability and cause dependence readily. Emphasis will be placed on demonstration of a rodent model in which butorphanol administration induces dependence through a unique (in comparison with morphine) activation of the kappa-opioid receptor. The use of in vivo microdialysis techniques clearly identifies, in this model, that acutely-precipitated withdrawal from dependence on butorphanol results in focal increases in extracellular levels of glutamate within the locus coeruleus, and that the withdrawal syndrome can be mimicked by intracerebroventricular administration of exogenous glutamate, acting through the N-methyl-D-aspartate glutamate receptor subtype. The data confirm the participation of glutamate as a general phenomenon in opioid dependence, identify the locus coeruleus as a primary site for glutamatergic mediation of dependence, and suggest novel aspects to the neuropharmacology of opioid dependence with respect to the role of the kappa-opioid receptor.
Authors:
I K Ho; Y Z Feng; S Tokuyama; K Hoshi; R W Rockhold
Related Documents :
19403616 - Opioid receptor mechanisms at the hypoglossal motor pool and effects on tongue muscle a...
2411916 - On the potassium conductance increased by opioids in rat locus coeruleus neurones.
20633136 - Evolution of the opioid/orl-1 receptor gene family.
10814826 - An alternatively spliced transcript of the rat nociceptin receptor orl1 gene encodes a ...
1283616 - Interactions of lithium with the adrenergic system in electrically-stimulated guinea pi...
22679016 - Chronic opioid potentiates presynaptic but impairs postsynaptic n-methyl-d-aspartic aci...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology     Volume:  17     ISSN:  1340-2544     ISO Abbreviation:  Nihon Shinkei Seishin Yakurigaku Zasshi     Publication Date:  1997 Aug 
Date Detail:
Created Date:  1998-01-09     Completed Date:  1998-01-09     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9509023     Medline TA:  Nihon Shinkei Seishin Yakurigaku Zasshi     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  175-80     Citation Subset:  IM    
Affiliation:
Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson 39216-4505, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analgesics, Opioid
Animals
Butorphanol
Glutamic Acid / physiology*
Locus Coeruleus / physiology
Microdialysis
Opioid-Related Disorders*
Rats
Receptors, Opioid, kappa / physiology
Substance Withdrawal Syndrome
Grant Support
ID/Acronym/Agency:
DA-05828/DA/NIDA NIH HHS
Chemical
Reg. No./Substance:
0/Analgesics, Opioid; 0/Receptors, Opioid, kappa; 42408-82-2/Butorphanol; 56-86-0/Glutamic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Histaminergic neuron system and neural plasticity
Next Document:  Haemodynamic responses to sevoflurane compared with halothane during inhalational induction in child...